Physical Activity and Inactivity in Lung Cancer Survivors

Lung Cancer Survivors Clinical Trial

Official title:

Physical Activity and Inactivity in Lung Cancer Survivors

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00582348
• Other study ID #: 05-094
• Secondary ID: Grant # CA115212
• Status: Completed
• Start date: September 2005
• Est. completion date: February 10, 2020

Study information

• Verified date: February 2020
• Source: Memorial Sloan Kettering Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to learn how often lung cancer survivors exercise. We also want to learn what helps people to be active or prevents them from being active. Learning this will help us to expand services for lung cancer survivors.

Description:

Despite the potential benefits of physical activity, particularly for cancer survivors with comorbid pulmonary and cardiac conditions, no previous research has examined the physical activity levels of lung cancer survivors, an underrepresented subpopulation in cancer survivorship research. We address this research gap in the current study, in which a random sample of 200 lung cancer survivors will complete a comprehensive telephone interview or use self-report to complete a questionnaire focusing on physical activity, related covariates, and preferences regarding physical activity counseling and interventions. We estimate the total time for the completion of the interview or self-report questionnaire to be 45-60 minutes. This study will be conducted with survivors of primary lung cancer who are from 1 to 5 years posttreatment and were treated at Memorial Sloan-Kettering Cancer Center (MSKCC).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 188
• Est. completion date: February 10, 2020
• Est. primary completion date: February 10, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Diagnosis of primary Stage IA or IB NSCLC;

• Underwent surgical resection for NSCLC at MSKCC;

• From 1 to 5 years post-treatment for NSCLC prior to study recruitment;

• No evidence of disease (NED) at the time of recruitment;

• Can be reached by telephone;

• Able to provide informed consent.

Exclusion Criteria:

• Undergoing active antineoplastic treatment;

• Major psychopathology or cognitive impairment likely in the judgment of the investigator to interfere with participation and compliance with the protocol.

Related Conditions & MeSH terms

• Lung Cancer Survivors
• Lung Neoplasms

Locations

Country	Name	City	State
United States	Memorial Sloan-Kettering Cancer Center	New York	New York

Sponsors (2)

Lead Sponsor	Collaborator
Memorial Sloan Kettering Cancer Center	National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The primary outcomes of this study are physical activity levels and preferences regarding physical activity counseling and interventions		45-60 minutes

External Links

•   Memorial Sloan-Kettering Cancer Center website